Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

TBRIA (calcitonin-salmon) for the Treatment of Postmenopausal Osteoporosis

Drug (Brand / Generic)

TBRIA / calcitonin-salmon [rDNA origin] delayed release tablets


Tarsa Therapeutics

Therapy Class

Salmon Calcitonin (r-DNA origin)

Current Indication

Postmenopausal osteoporosis

Market Sector


Development Status

NDA under review by the US FDA

Go Top